Cargando…
Associations between PM(2.5) and Heart Rate Variability Are Modified by Particle Composition and Beta-Blocker Use in Patients with Coronary Heart Disease
BACKGROUND: It has been hypothesized that ambient particulate air pollution is able to modify the autonomic nervous control of the heart, measured as heart rate variability (HRV). Previously we reported heterogeneous associations between particulate matter with aerodynamic diameter < 2.5 μm (PM(2...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
National Institute of Environmental Health Sciences
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2627852/ https://www.ncbi.nlm.nih.gov/pubmed/19165395 http://dx.doi.org/10.1289/ehp.11062 |
_version_ | 1782163603703463936 |
---|---|
author | de Hartog, Jeroen J. Lanki, Timo Timonen, Kirsi L. Hoek, Gerard Janssen, Nicole A.H. Ibald-Mulli, Angela Peters, Annette Heinrich, Joachim Tarkiainen, Tuula H. van Grieken, Rene van Wijnen, Joop H. Brunekreef, Bert Pekkanen, Juha |
author_facet | de Hartog, Jeroen J. Lanki, Timo Timonen, Kirsi L. Hoek, Gerard Janssen, Nicole A.H. Ibald-Mulli, Angela Peters, Annette Heinrich, Joachim Tarkiainen, Tuula H. van Grieken, Rene van Wijnen, Joop H. Brunekreef, Bert Pekkanen, Juha |
author_sort | de Hartog, Jeroen J. |
collection | PubMed |
description | BACKGROUND: It has been hypothesized that ambient particulate air pollution is able to modify the autonomic nervous control of the heart, measured as heart rate variability (HRV). Previously we reported heterogeneous associations between particulate matter with aerodynamic diameter < 2.5 μm (PM(2.5)) and HRV across three study centers. OBJECTIVES: We evaluated whether exposure misclassification, effect modification by medication, or differences in particle composition could explain the inconsistencies. METHODS: Subjects with coronary heart disease visited clinics biweekly in Amsterdam, the Netherlands; Erfurt, Germany; and Helsinki, Finland for 6–8 months. The standard deviation (SD) of NN intervals on an electrocardiogram (ECG; SDNN) and high frequency (HF) power of HRV was measured with ambulatory ECG during paced breathing. Outdoor levels of PM(2.5) were measured at a central site. In Amsterdam and Helsinki, indoor and personal PM(2.5) were measured during the 24 hr preceding the clinic visit. PM(2.5) was apportioned between sources using principal component analyses. We analyzed associations of indoor/personal PM(2.5), elements of PM(2.5), and source-specific PM(2.5) with HRV using linear regression. RESULTS: Indoor and personal PM(2.5) were not associated with HRV. Increased outdoor PM(2.5) was associated with decreased SDNN and HF at lags of 2 and 3 days only among persons not using beta-blocker medication. Traffic-related PM(2.5) was associated with decreased SDNN, and long-range transported PM(2.5) with decreased SDNN and HF, most strongly among persons not using beta blockers. Indicators for PM(2.5) from traffic and long-range transport were also associated with decreased HRV. CONCLUSIONS: Our results suggest that differences in the composition of particles, beta-blocker use, and obesity of study subjects may explain some inconsistencies among previous studies on HRV. |
format | Text |
id | pubmed-2627852 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | National Institute of Environmental Health Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-26278522009-01-22 Associations between PM(2.5) and Heart Rate Variability Are Modified by Particle Composition and Beta-Blocker Use in Patients with Coronary Heart Disease de Hartog, Jeroen J. Lanki, Timo Timonen, Kirsi L. Hoek, Gerard Janssen, Nicole A.H. Ibald-Mulli, Angela Peters, Annette Heinrich, Joachim Tarkiainen, Tuula H. van Grieken, Rene van Wijnen, Joop H. Brunekreef, Bert Pekkanen, Juha Environ Health Perspect Research BACKGROUND: It has been hypothesized that ambient particulate air pollution is able to modify the autonomic nervous control of the heart, measured as heart rate variability (HRV). Previously we reported heterogeneous associations between particulate matter with aerodynamic diameter < 2.5 μm (PM(2.5)) and HRV across three study centers. OBJECTIVES: We evaluated whether exposure misclassification, effect modification by medication, or differences in particle composition could explain the inconsistencies. METHODS: Subjects with coronary heart disease visited clinics biweekly in Amsterdam, the Netherlands; Erfurt, Germany; and Helsinki, Finland for 6–8 months. The standard deviation (SD) of NN intervals on an electrocardiogram (ECG; SDNN) and high frequency (HF) power of HRV was measured with ambulatory ECG during paced breathing. Outdoor levels of PM(2.5) were measured at a central site. In Amsterdam and Helsinki, indoor and personal PM(2.5) were measured during the 24 hr preceding the clinic visit. PM(2.5) was apportioned between sources using principal component analyses. We analyzed associations of indoor/personal PM(2.5), elements of PM(2.5), and source-specific PM(2.5) with HRV using linear regression. RESULTS: Indoor and personal PM(2.5) were not associated with HRV. Increased outdoor PM(2.5) was associated with decreased SDNN and HF at lags of 2 and 3 days only among persons not using beta-blocker medication. Traffic-related PM(2.5) was associated with decreased SDNN, and long-range transported PM(2.5) with decreased SDNN and HF, most strongly among persons not using beta blockers. Indicators for PM(2.5) from traffic and long-range transport were also associated with decreased HRV. CONCLUSIONS: Our results suggest that differences in the composition of particles, beta-blocker use, and obesity of study subjects may explain some inconsistencies among previous studies on HRV. National Institute of Environmental Health Sciences 2009-01 2008-08-25 /pmc/articles/PMC2627852/ /pubmed/19165395 http://dx.doi.org/10.1289/ehp.11062 Text en http://creativecommons.org/publicdomain/mark/1.0/ Publication of EHP lies in the public domain and is therefore without copyright. All text from EHP may be reprinted freely. Use of materials published in EHP should be acknowledged (for example, ?Reproduced with permission from Environmental Health Perspectives?); pertinent reference information should be provided for the article from which the material was reproduced. Articles from EHP, especially the News section, may contain photographs or illustrations copyrighted by other commercial organizations or individuals that may not be used without obtaining prior approval from the holder of the copyright. |
spellingShingle | Research de Hartog, Jeroen J. Lanki, Timo Timonen, Kirsi L. Hoek, Gerard Janssen, Nicole A.H. Ibald-Mulli, Angela Peters, Annette Heinrich, Joachim Tarkiainen, Tuula H. van Grieken, Rene van Wijnen, Joop H. Brunekreef, Bert Pekkanen, Juha Associations between PM(2.5) and Heart Rate Variability Are Modified by Particle Composition and Beta-Blocker Use in Patients with Coronary Heart Disease |
title | Associations between PM(2.5) and Heart Rate Variability Are Modified by Particle Composition and Beta-Blocker Use in Patients with Coronary Heart Disease |
title_full | Associations between PM(2.5) and Heart Rate Variability Are Modified by Particle Composition and Beta-Blocker Use in Patients with Coronary Heart Disease |
title_fullStr | Associations between PM(2.5) and Heart Rate Variability Are Modified by Particle Composition and Beta-Blocker Use in Patients with Coronary Heart Disease |
title_full_unstemmed | Associations between PM(2.5) and Heart Rate Variability Are Modified by Particle Composition and Beta-Blocker Use in Patients with Coronary Heart Disease |
title_short | Associations between PM(2.5) and Heart Rate Variability Are Modified by Particle Composition and Beta-Blocker Use in Patients with Coronary Heart Disease |
title_sort | associations between pm(2.5) and heart rate variability are modified by particle composition and beta-blocker use in patients with coronary heart disease |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2627852/ https://www.ncbi.nlm.nih.gov/pubmed/19165395 http://dx.doi.org/10.1289/ehp.11062 |
work_keys_str_mv | AT dehartogjeroenj associationsbetweenpm25andheartratevariabilityaremodifiedbyparticlecompositionandbetablockeruseinpatientswithcoronaryheartdisease AT lankitimo associationsbetweenpm25andheartratevariabilityaremodifiedbyparticlecompositionandbetablockeruseinpatientswithcoronaryheartdisease AT timonenkirsil associationsbetweenpm25andheartratevariabilityaremodifiedbyparticlecompositionandbetablockeruseinpatientswithcoronaryheartdisease AT hoekgerard associationsbetweenpm25andheartratevariabilityaremodifiedbyparticlecompositionandbetablockeruseinpatientswithcoronaryheartdisease AT janssennicoleah associationsbetweenpm25andheartratevariabilityaremodifiedbyparticlecompositionandbetablockeruseinpatientswithcoronaryheartdisease AT ibaldmulliangela associationsbetweenpm25andheartratevariabilityaremodifiedbyparticlecompositionandbetablockeruseinpatientswithcoronaryheartdisease AT petersannette associationsbetweenpm25andheartratevariabilityaremodifiedbyparticlecompositionandbetablockeruseinpatientswithcoronaryheartdisease AT heinrichjoachim associationsbetweenpm25andheartratevariabilityaremodifiedbyparticlecompositionandbetablockeruseinpatientswithcoronaryheartdisease AT tarkiainentuulah associationsbetweenpm25andheartratevariabilityaremodifiedbyparticlecompositionandbetablockeruseinpatientswithcoronaryheartdisease AT vangriekenrene associationsbetweenpm25andheartratevariabilityaremodifiedbyparticlecompositionandbetablockeruseinpatientswithcoronaryheartdisease AT vanwijnenjooph associationsbetweenpm25andheartratevariabilityaremodifiedbyparticlecompositionandbetablockeruseinpatientswithcoronaryheartdisease AT brunekreefbert associationsbetweenpm25andheartratevariabilityaremodifiedbyparticlecompositionandbetablockeruseinpatientswithcoronaryheartdisease AT pekkanenjuha associationsbetweenpm25andheartratevariabilityaremodifiedbyparticlecompositionandbetablockeruseinpatientswithcoronaryheartdisease |